BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/15/2019 10:50:47 AM | Browse: 1376 | Download: 2147
 |
Received |
|
2019-01-11 06:25 |
 |
Peer-Review Started |
|
2019-01-11 09:03 |
 |
First Decision by Editorial Office Director |
|
2019-01-26 18:36 |
 |
Return for Revision |
|
2019-01-28 09:15 |
 |
Revised |
|
2019-02-16 13:04 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2019-02-26 08:24 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2019-02-28 04:15 |
 |
Articles in Press |
|
2019-02-28 04:15 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2019-04-15 02:27 |
 |
Publish the Manuscript Online |
|
2019-04-15 10:50 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Up-regulation of tumor necrosis factor-α pathway survival genes and of the receptor TNFR2 in gastric cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ana Flávia Teixeira Rossi, Julia Cocenzo Contiero, Fernanda da Silva Manoel-Caetano, Fábio Eduardo Severino and Ana Elizabete Silva |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| São Paulo Research Foundation-FAPESP |
2015/21464-0 |
| São Paulo Research Foundation-FAPESP |
2015/23392-7 |
| National Counsel of Technological and Scientific Development-CNPq |
140723/2015-3 |
|
| Corresponding Author |
Ana Elizabete Silva, PhD, Adjunct Professor, Department of Biology, São Paulo State University – UNESP, Rua Cristóvão Colombo, 2265, São José do Rio Preto SP 15054-000, Brazil. ae.silva@unesp.br |
| Key Words |
Gastric cancer; Tumor necrosis factor-α signaling; TNFR1; TNFR2; Cellular survival; MicroRNAs |
| Core Tip |
We evaluated the expression of mRNA and microRNAs (miRNAs) related to the tumor necrosis factor (TNF)-α signaling pathway in gastric cancer (GC) fresh tissues. Our study shows up-regulation of cell survival genes (TNF, TNFR2, TRADD, TRAF2, CFLIP, NFKB2, CASP8) of this signaling pathway in GC, stimulating cell growth possibly by TNFR2 and negatively controls TNFR1-mediated apoptosis by down-regulation of pro-apoptotic mediators (TNFR1 and CASP3). Furthermore, interaction network between miRNAs and mRNA investigated suggests that TNF-α signaling pathway can be regulated by the action of miRNAs, mainly miR-19a and miR-103a, which may influence tumor development. Ours findings suggest TNFR2 as a potential therapeutic target for GC. |
| Publish Date |
2019-04-15 10:50 |
| Citation |
Rossi AFT, Contiero JC, Manoel-Caetano MS, Severino FE, Silva AE. Up-regulation of tumor necrosis factor-α pathway survival genes and of the receptor TNFR2 in gastric cancer. World J Gastrointest Oncol 2019; 11(4): 281-294 |
| URL |
https://www.wjgnet.com/1948-5204/full/v11/i4/281.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v11.i4.281 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.